Effects of tolbutamide on ATP-sensitive K+ channels from human right atrial cardiac myocytes

Pharmacology and Toxicology

Volumn 80, Issue 2, 1997, Pages 69-75

  Zünkler, Bernd J ^a,c   Henning, Berthold ^b   Ott, Tilmann ^a   Hildebrandt, Alfred G ^a   Fleck, Eckart ^b  

^a Federal Institute for Drugs and Medical Devices   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c Fed Inst Drugs and Med Devices   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CROMAKALIM; POTASSIUM CHANNEL; TOLBUTAMIDE;

ARTICLE; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; HEART ATRIUM MUSCLE; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; ION CONDUCTANCE; PATCH CLAMP; PRIORITY JOURNAL;

EID: 0031041222     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1997.tb00286.x     Document Type: Article

References (34)

1. Aguilar-Bryan, L., C. G. Nichols, S. W. Wechsler, J. P. Clement IV, A. E. Boyd III, G. Gonzalez, H. Herrera-Sosa, K. Nguy, J. Bryan & D. A. Nelson: Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995, 268, 423-426.
2. Ashcroft, F. M.: Adenosine 5′-triphosphate-sensitive potassium channels. Ann. Rev. Neorosci. 1988, 11, 97-118.
3. Belles, B., J. Hescheler & G. Trube: Changes of membrane current in cardiac cells induced by long whole-cell recordings and tolbutamide. Pflügers Arch. 1987, 409, 582-588.
4. Cacciapuoti, F., R. Spiezia, U. Bianchi, D. Lama, M. D'Avino & M. Varricchio: Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus. Amer. J. Cardiol. 1991, 67, 843-847.
5. Coetzee, W. A.: ATP-sensitive potassium channels and myocardial ischemia: why do they open? Cardiovasc. Drugs Therap. 1992, 6, 201-208.
6. Cohen, N. M., W. J. Lederer & C. G. Nichols: Activation of ATP-sensitive potassium channels underlies contractile failure in single human cardiac myocytes during complete metabolic inhibition. J. Cardiovasc. Electrophysiol. 1992, 3, 56-63.
7. + channels in guinea-pig cardiac myocytes. Pflügers Arch. 1989, 414, 669-675.
8. + channels in cardiac muscle. J. Pharmacol. Exp. Therap. 1992, 262, 71-79.
9. + channels during metabolic stress in cardiac muscle. J. Pharmacol. Exp. Therap. 1993, 266, 456-467.
10. + channels. J. Biol. Chem. 1988, 263, 7933-7936.
11. Gross, G. J.: ATP-sensitive potassium channels and myocardial preconditioning. Basic Res. Cardiol. 1995, 90, 85-88.
12. Hamill, O. P., A. Marty, E. Neher, B. Sakmann & F. J. Sigworth: Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patches. Pflügers Arch. 1981, 391, 85-100.
13. Huupponen, R.: Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance. Med. Toxicol. 1987, 2, 190-209.
14. Inagaki, N., T. Gonoi, J. P. Clement IV, N. Namba, J. Inazawa, G. Gonzalez, L. Aguilar-Bryan, S. Seino & J. Bryan: Reconstitution of I: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995, 270, 1166-1170.
15. + channels. Neuron 1996, 16, 1011-1017.
16. Krause, E., H. Englert & H. Gögelein: Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Pflügers Arch. 1995, 429, 625-635.
17. Leibowitz, G. & E. Cerasi: Sulphonylurea treatment of NIDDM patients with cardiovascular disease. Diabetologia 1996, 39, 503-514.
18. Nichols, C. G. & W. J. Lederer: Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Amer. J. Physiol. 1991, 261, H1675-H1686.
19. + channels in cardiac muscle. Nature 1983, 305, 147-148.
20. Ogbaghebriel, A. & A. Shrier: Differential responsiveness of atrial and ventricular myocytes to potassium channel openers. J. Cardiovasc. Pharmacol. 1995, 25, 65-74.
21. + currents of mouse pancreatic β-cells. Pflügers Arch. 1987, 408, 133-138.
22. Panten, U., J. Burgfeld, F. Goerke, M. Rennicke, M. Schwanstecher, A. Wallasch, B. J. Zünkler & S. Lenzen: Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem. Pharmacol. 1989, 38, 1217-1229.
23. + channel in mouse pancreatic B-cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 1990, 342, 566-574.
24. Panten, U., M. Schwanstecher & C. Schwanstecher: Pancreatic and extrapancreatic sulfonylurea receptors. Horm. Metab. Res. 1992, 24, 549-554.
25. + channel in mouse β-cells. Brit. J. Pharmacol. 1994, 111, 302-310.
26. Sturgess, N. C., M. L. J. Ashford, D. Cook & C. N. Hales: The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985, 8453, 474-475.
27. + channel blocker. Circulation 1994, 90, 700-705.
28. + channel in mouse pancreatic β-cells. Pflügers Arch. 1986, 407, 493-499.
29. University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II, Mortality results. Diabetes 1970, 19 (suppl 2), 789-830.
30. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ. Res. 1991, 69, 623-637.
31. Wilde, A. A. M. & M. J. Janse: Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc. Res. 1994, 28, 16-24.
32. + currents in pancreatic B-cells. Naunyn Schmiedeberg's Arch. Pharmacol. 1988a, 337, 225-230.
33. + channels from pancreatic B-cells. FEBS Lett. 1988b, 239, 241-244.
34. Zünkler, B. J., G. Trube & U. Panten: How do sulfonylureas approach their receptor in the B-cell plasma membrane? Naunyn-Schmiedeberg's Arch. Pharmacol. 1989, 340, 328-332.